Gencove
New York, US · Founded 2016 · Delaware corporation · 14 employees on LinkedIn · 6 known investors
Gencove provides direct-to-consumer genetic sequencing and polygenic risk scoring for health insights. The service analyzes DNA samples to deliver personalized health recommendations across core health areas, ancestry information, and integrates with labs, wearables, and lifestyle data.
Founders & leadership
Gencove was founded in 2016 by Tomaz Berisa and Joseph Pickrell.
TB
Tomaz BerisaCo-founder
JP
Joseph PickrellCo-founder
Board
SE
Investors · 6
Bread And Butter Ventures, LlcMinneapolis · $100K – $250K
Spero VenturesBurlingame · $2M – $4Mvia Shripriya Mahesh · board
Balaji Srinivasanreported$10K – $500K
Refactor CapitalreportedBurlingame · $1M – $2M
Third Kind Venture CapitalreportedNew York · $50K – $5M
Version One VenturesreportedVancouver · $250K – $500K
Reported raises · per SEC filings
Form D private placements$15.3M disclosed across 4 rounds · 2017–2021
▶$9.8MraisedNov 2021 · 8 investors · Other TechnologyRule 506(b)
▶$9.8MraisedNov 2021 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Larry PageDirector
- Sara EshelmanDirector
- Joseph PickrellExecutive Officer, Director
- Tomaz BerisaExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $9.8M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedApr 2021 · 10 investors · Other TechnologyRule 506(b)
▶$1.8MraisedApr 2021 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Tomaz BerisaExecutive Officer, Director
- Sara EshelmanDirector
- Joseph PickrellExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.7MraisedFeb 2019 · 5 investors · Other TechnologyRule 506(b)
▶$2.7MraisedFeb 2019 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Shripriya MaheshDirector
- Tomaz BerisaExecutive Officer, Director, Promoter
- Joseph PickrellExecutive Officer, Director, Promoter
- Offering amount
- $3M
- Amount sold
- $2.7M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1MraisedJun 2017 · 7 investors · Other TechnologyRule 506(b)
▶$1MraisedJun 2017 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Tomaz BerisaExecutive Officer, Director, Promoter
- Joseph PickrellExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $10K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlap
IDbyDNA40 shared keywordsScalable, high throughput DNA sequencing platforms.
Sequencing17 shared keywordsSequencing.com provides whole genome sequencing with a DNA collection kit and DNA reports offering health, wellness, and pharmacogenomic insights for consumers. It offers an optional subscription that reanalyzes a customer's genome monthly against the latest research and gives full access to raw and analyzed genetic data.
Genewiz15 shared keywordsGENEWIZ, part of Azenta Life Sciences, provides genomics laboratory services including next-generation and Sanger sequencing, gene synthesis, oligo synthesis, plasmid DNA preparation, proteomics, and GLP-compliant and clinical services. It serves researchers and life science organizations working in areas such as cancer genomics, cell and gene therapy, synthetic biology, and infectious disease.
Genedx14 shared keywordsGeneDx provides genetic testing for rare and inherited conditions, including exome, genome, trio, and prenatal sequencing, paired with clinical interpretation and a large rare disease dataset. It serves clinicians, patients, and biopharma partners to support earlier diagnoses and precision medicine.
Oup13 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Nucleus Genomics11 shared keywordsNucleus provides genetic testing and analysis for couples planning pregnancy, screening for over 200 hereditary diseases, traits, and health conditions. For those undergoing IVF, the company offers embryo selection guidance to reduce disease risk and optimize traits including eye color, height, and intelligence.
Companies competing with Gencove for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $330.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Gencove do?
- Gencove provides direct-to-consumer genetic sequencing and polygenic risk scoring for health insights. The service analyzes DNA samples to deliver personalized health recommendations across core health areas, ancestry information, and integrates with labs, wearables, and lifestyle data.
- Who founded Gencove?
- Gencove was founded by Tomaz Berisa, Joseph Pickrell in 2016.
- Who are Gencove's investors?
- Gencove's investors include Bread And Butter Ventures, Llc, Spero Ventures, Balaji Srinivasan, Refactor Capital, Third Kind Venture Capital, Version One Ventures.
- How much funding has Gencove raised?
- Gencove has disclosed $15.3M raised across 4 rounds.
- Where is Gencove headquartered?
- Gencove is headquartered in New York, US.